ALTERITY THERAPEUTICS-ADR (ATHE) Stock Income Statement
NASDAQ:ATHE - Nasdaq - US02155X2053 - ADR - Currency: USD
| 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 268.42K | 16.44K | 2.50K | 20.68K | 17.12K | |||
| Operating Expenses | 19.61M | 14.64M | 15.96M | 15.39M | 13.93M | |||
| Research and Development | 18.64M | 13.20M | 14.75M | 12.28M | 10.10M | |||
| Selling, General, and Administrative Expenses | 4.84M | 5.22M | 5.82M | 7.16M | 3.67M | |||
| Operating Income | -19.34M | -14.62M | -15.95M | -15.37M | -13.91M | |||
| Interest Income/Expense | 261.15K | 917.65K | 2.72M | -297.11K | 333.06K | |||
| Other Income/Expense | 0.00 | 2.10K | 454.12K | 213.24K | N/A | |||
| Non Recurring Items | 0.00 | 0.00 | 0.00 | 145.63K | 122.73K | |||
| Income Before Taxes | -19.08M | -13.70M | -12.78M | -15.31M | -13.46M | |||
| Income Tax | 46.09K | 104.46K | 70.01K | 0.00 | 0.00 | |||
| Net Income | -19.12M | -13.81M | -12.85M | -15.31M | -13.46M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.87 | -3.12 | -2.93 | -4.95 | -8.25 | |||
| Statistics | ||||||||
| Profit Margin | -7124.45% | -83981.27% | -513882.40% | -74029.74% | -78602.80% | |||
| Operating Profit Margin | -7204.58% | -88940.45% | -638144.40% | -74328.34% | -81265.07% | |||
All data in AUD